Skip to main content
Joseph Sparano, MD, Oncology, New York, NY

JosephASparanoMD

Oncology New York, NY

Breast Cancer

Ezra M Greenspan MD Professor of Clinical Cancer Therapeutics; Chief, Division of Hematology and Medical Oncology; Deputy Director, Tisch Cancer Institute; Icahn School of Medicine at Mount Sinai, NY, NY

Dr. Sparano is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sparano's full profile

Already have an account?

  • Office

    1425 Madison Avenue
    New York, NY 10029
    Phone+1 212-659-6754

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 1986 - 1987
  • New York Medical College at St Vincent's Hospital and Medical Center of New York
    New York Medical College at St Vincent's Hospital and Medical Center of New YorkResidency, Internal Medicine, 1982 - 1985
  • New York Medical College
    New York Medical CollegeClass of 1982

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1985 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • New York Magazine: Top Doctors Castle Connolly, 2002, 2006, 2018
  • Top Doctors: New York Metro Area Castle Connolly, 2003-2008, 2010-2014
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Deconstructing Racial and Ethnic Disparities in Breast Cancer  
    Joseph A Sparano, Otis W Brawley, JAMA Oncology
  • Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer  
    Matthew P Goetz, Thomas J Saphner, Joseph A Sparano, Lynne I Wagner, Peter M Ravdin, Daniel F Hayes, Adam M Brufsky, Della F Makower, Sunil S Badve, Robert J Gray, Wil..., The New England Journal of Medicine

Abstracts/Posters

  • Response-Adapted Therapy with Infusional EPOCH Chemotherapy Plus Rituximab in HIV-Associated, B-Cell Non-Hodgkin's Lymphoma
    Joseph Sparano, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • A Randomized Trial of EPOCH-Based Chemotherapy with Vorinostat for Highly Aggressive HIV-Associated Lymphomas: Updated Results Evaluating Impact of Diagnosis-to-Treatm...
    Joseph Sparano, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Impact of clinical risk category on prognosis and prediction of chemotherapy benefit in early breast cancer (EBC) by age and the 21-gene recurrence score (RS) in TAILORx. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Selected Updates in Breast Cancer 
    2007 Annual Meeting, Chicago, Illinois, USA

Press Mentions

  • TAILORx Update: 12-Year Recurrence and Survival Outcomes for Patients with Early-Stage Breast Cancer
    TAILORx Update: 12-Year Recurrence and Survival Outcomes for Patients with Early-Stage Breast CancerDecember 13th, 2022
  • SABCS: Updated Analysis Confirms Endocrine Therapy Effective With/Without Chemo
    SABCS: Updated Analysis Confirms Endocrine Therapy Effective With/Without ChemoDecember 12th, 2022
  • Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC Guidelines
    Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC GuidelinesDecember 12th, 2022
  • Join now to see all

Grant Support

  • Albert Einstein Core SiteNational Cancer Institute2010–2011
  • Centralized Protocol And Data Management UnitNational Cancer Institute2007–2011
  • Eastern Cooperative Oncology GroupNational Cancer Institute2004–2011
  • Montefiore Medical Center / Albert Einstein School Of MedicineNational Cancer Institute2006
  • AIDS Malignancy ConsortiumNational Cancer Institute1999–2005
  • Eastern Cooperative Oncology GroupNational Cancer Institute2002–2003

Professional Memberships